2017 OZARK BIOMEDICAL INITIATIVE RESEARCH SYMPOSIUM
This symposium will open with a keynote presentation entitled “Accessing NIH’s Research Dollars: An Insider’s Perspective on Funding Options and Strategies” by Dr. Lenka Fedorkova , founder and CEO of bioPrime, LLC and former NIH/SBIR manager. Short presentations from OBI REC grant recipients will follow. A poster session showcasing research at Missouri S&T and PCRMC will be included, along with image processing presentations, due to this year’s merger of the OBIRS and Image Processing Symposium.
Saturday, Aug. 19, 2017
Dr. Lenka Fedorkova is the Founder and CEO of bioPrime, LLC, which is dedicated to facilitating and promoting commercialization of early-stage biomedical innovations and helping entrepreneurs secure NIH funding through the SBIR/STTR programs. Dr. Fedorkova is a former manager and coordinator of the NIH SBIR/STTR programs across the agency's 24 funding Institutes and Centers, where she ran NIH's flagship Commercialization Assistance Program. She spearheaded the development of funding programs, including the Commercialization Readiness Program, I-Corps assistance program, Innovation Zone, which is a technology showcased partnered with the Biotechnology Industry Organization, amongst other initiaitves. Notably, she has directly worked with many successful NIH awardees on developing successful commercialization strategies. Dr. Lenka Federkova will share practical tips and lessons for aspiring entrepreneurs to help them effectively navigate through and understand NIH's research priorities, funding options, the review process, and important due diligence strategies for preparing a competitive application for SBIR/STTR programs and beyond.
What is the Ozark Biomedical Initiative?
Medical communities led by Phelps County Regional Medical Center (PCRMC, Rolla, Missouri) and Missouri’s premier technological research institution, Missouri University of Science and Technology (Missouri S&T, Rolla, Missouri), have a long history of serving the Rolla area and the state of Missouri. Building upon the success of these institutions, a strategic partnership, the Ozark Biomedical Initiative (OBI), was established in July 2015 to promote collaborative research and education activities between these institutions.
The OBI will combine leading expertise of technological research and healthcare practices to leverage and share participating institutions’ infrastructures of scholarly activities, clinical experiences, laboratory facilities and technology transfer. Research and educational activities of this partnership include, but are not limited to, hosting regular symposiums, developing joint academic/clinical programs and sharing staff members' expertise to push the horizon of cutting-edge biomedical advances ranging from biomaterials development, cancer theranostics, stem cell research and bioinstrumentations to healthcare informatics (Read More).
For more information
Please email us at email@example.com.